GlassScriptPhysician profile
Atul Chandoke
NPI 1770782419
$11,349.94
in general payments reported to CMS, 2019-2025
20 companies · $317 in 2025
The $317 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,485 · 2020: $1,693 · 2021: $2,197 · 2022: $2,327 · 2023: $1,511 · 2024: $819 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,647.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,089.85 | 2019-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $799.99 | 2019-2022 | |
| Medtronic, INC. | $485.15 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $398.49 | 2019-2020 | |
| Stimwave Technologies Incorporated | $294.13 | 2021-2022 | |
| Vertos Medical, INC. | $291.57 | 2020-2022 | |
| Nevro Corp. | $225.93 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $120.00 | 2021 | |
| Assertio Therapeutics, INC. | $117.62 | 2019 | |
| Curonix LLC | $116.58 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Teva Pharmaceuticals USA, INC. | $89.64 | 2019-2020 | |
| Kaleo, INC. | $55.60 | 2019 | |
| Daiichi Sankyo INC. | $53.84 | 2019 | |
| Arbor Pharmaceuticals, INC. | $44.28 | 2019 | |
| Bioventus LLC | $39.46 | 2019-2025 | Durolane |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $34.69 | 2019 | |
| Stryker Corporation | $29.44 | 2024 | Omnicurve |
| Amgen INC. | $24.04 | 2020 | |
| Si-Bone, INC. | $22.60 | 2019 | |
| Pfizer INC. | $17.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atul Chandoke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.